Eulerpool Terminal
The edge that pays for itself.
Current TScan Therapeutics forecasts and price targets in August 2026
Ø Analyst Price Targets
7.14 USD
+830.90 %
Median
6.12 USD
+697.91 %
Max
12.60 USD
Min
4.04 USD
Last Price
0.77 USD
Buy
10
Hold
3
Sell
0
The average target price for TScan Therapeutics is 7.14 USD. (+830.90 % above the current price)
The median price target of TScan Therapeutics is 6.12 USD.
Stock analysts from many renowned investment banks are closely examining the TScan Therapeutics stock. They conclude their professional TScan Therapeutics stock analyses with a clear recommendation for the TScan Therapeutics stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 10 | 3 | 0 | 7.14 USD |
| 2026-01-01 | 10 | 3 | 0 | 7.14 USD |
| 2025-12-01 | 10 | 3 | 0 | 7.14 USD |
| 2025-12-01 | 10 | 3 | 0 | 7.14 USD |
| 2025-11-01 | 13 | 1 | 0 | 6.46 USD |
| 2025-11-01 | 13 | 1 | 0 | 8.67 USD |
TScan Therapeutics Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for TScan Therapeutics in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2025e | 10.00 M USD | -62.00 M USD | -0.55 USD |
| 2026e | 8.00 M USD | -51.00 M USD | -0.46 USD |
| 2027e | 13.00 M USD | -49.00 M USD | -0.44 USD |